Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth)

Navigation and Search
Photo of Muhammad Tariq, MD, presenting at the Society of NeuroInterventional Surgery’s 18th Annual Meeting.

Women less likely than men to receive opportune care after stroke, study finds

Women are less likely than men to receive timely care for strokes caused by blockages in large vessels, known as emergent large vessel occlusion (ELVO), according to researchers with The University of Texas Health Science Center at Houston (UTHealth).

A $6 million grant from the National Institute on Aging will help investigators with UTHealth advance Alzheimer's disease research. (Photo by Getty Images)

New grant to help advance Alzheimer's disease research

A five-year, nearly $6 million grant from the National Institute on Aging will allow investigators with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics to use artificial intelligence (AI) to advance Alzheimer’s disease research.

Group photo of professionals who attended the 2021 CCTS annual meeting in Houston. (Photo by Rogelio Castro/UTHealth)

Center for Clinical and Translational Sciences addresses COVID-19 health disparities across Texas

Projects of the Center for Clinical and Translational Sciences include several initiatives to address testing disparities in vulnerable and underserved populations across the state, including in the Houston metro area, in South Texas, and in East Texas and West Texas, which have higher rates of uninsured and African American populations.

Researchers reviewing brain scans on a large screen in a meeting room. (Photo by Terry Vine Photography)

Medication approved for diabetes being tested for treatment of cocaine use disorder

With overdose rates involving cocaine soaring nearly 27% in 2020, researchers at The University of Texas Health Science Center at Houston (UTHealth) hope that a clinical trial combining a medication approved for the treatment of Type 2 diabetes with cognitive behavioral therapy (CBT) can help prevent relapse in cocaine use disorder patients.






More headlines »